Supplementary Table S3 from Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma Article Swipe
Related Concepts
Glioblastoma
Table (database)
Adverse effect
Oncology
Internal medicine
Medicine
Biology
Computer science
Cancer research
Data mining
Mary Jane Lim-Fat
,
J. Bryan Iorgulescu
,
Rifaquat Rahman
,
Varun Bhave
,
Alona Muzikansky
,
E. L. Woodward
,
Sydney Whorral
,
Marie Allen
,
Mehdi Touat
,
Xiaomei Li
,
Gongwen Xy
,
Jay Patel
,
Elizabeth R. Gerstner
,
Jayashree Kalpathy–Cramer
,
Gilbert Youssef
,
Ugonma Chukwueke
,
J Ricardo McFaline-Figueroa
,
Lakshmi Nayak
,
Eudocia Q. Lee
,
David A. Reardon
,
Rameen Beroukhim
,
Raymond Y. Huang
,
Wenya Linda Bi
,
Keith L. Ligon
,
Patrick Y. Wen
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.25515889
· OA: W4393382864
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.25515889
· OA: W4393382864
<p>Supplemental Table 3A: Univariate analysis of molecular alterations associated with seizure at diagnosis showing significant genes at a nominal p<0.05. Genes associated with seizures at a false discovery rate (FDR) <0.2 were tested in multivariable analyses (see Supplemental Table 4).</p>
Related Topics
Finding more related topics…